What is HydroCision?
HydroCision, Inc. is a privately held medical device firm recognized for its proprietary FluidJet technology. This innovative approach utilizes fluid jets for precise soft tissue removal without generating heat, establishing a unique patent estate. The company's technology finds application across diverse medical fields, including wound care, urology, spine surgery, interventional pain management, and orthopedic sports medicine, positioning it as a key player in minimally invasive surgical solutions.
How much funding has HydroCision raised?
HydroCision has raised a total of $36.5M across 10 funding rounds:
Series F
$5.2M
Series G
$12.7M
Debt
$3M
Debt
$623K
Private Equity
$3M
Other Financing Round
$4M
Debt
$150K
Debt
$279K
Series F (2002): $5.2M, investors not publicly disclosed
Series G (2006): $12.7M, investors not publicly disclosed
Debt (2008): $3M, investors not publicly disclosed
Debt (2010): $623K, investors not publicly disclosed
Private Equity (2017): $3M led by Volcano Capital, LLC and BioVentures Investors, LLC
Other Financing Round (2017): $4M supported by Tradewind International
Debt (2020): $150K featuring PPP
Debt (2021): $279K backed by PPP
Key Investors in HydroCision
Volcano Capital, LLC
Volcano Capital, LLC is a healthcare-focused investment firm that provides capital and operational expertise to grow businesses. They emphasize a collaborative approach, offering strategic guidance and access to a broad network of industry professionals, with a focus on early to mid-stage medical devices and healthcare services.
BioVentures Investors, LLC
BioVentures MedTech Funds is dedicated to investing in innovative companies developing advanced medical technologies. The firm focuses on emerging and growth-stage MedTech companies, providing capital and strategic advice to enhance value and drive successful exits.
Oxford Bioscience Partners
Oxford Bioscience Partners is an international venture capital firm specializing in life science technology investments, with a global presence and a focus on advancing innovative companies in the sector.
What's next for HydroCision?
The recent major strategic investment in HydroCision signals a pivotal growth phase for the company. This capital infusion is expected to accelerate the commercialization of its FluidJet technology, potentially expanding its market reach and further developing its product pipeline. The company's focus on a technology with broad applications across multiple surgical specialties suggests a strategic intent to capture significant market share and drive innovation in patient care.
See full HydroCision company page
